PUBLIC COMPANY
saveUCB SA
updated 2mo ago
community read0 votes
pipeline
19
marketed
12
phase 3
1
catalysts ytd
7
approvals ytd
7
recalls ytd
0
Pipeline(19)
view full pipeline →pipeline depth19 products
1Phase 21Phase 312Marketed5Unknown
Marketed
(chlorphenamine polistirex + hydrocodone) ER
Nasopharyngitis (Common Cold)
Marketed(doxecitine + doxribtimine)
Inherited Mitochondrial Disorders
MarketedBRIVARACETAM
Childhood Epilepsy
Synaptic vesicle glycoprotein 2A
MarketedLACOSAMIDE
Generalized Seizures
MarketedLEVETIRACETAM
Myoclonic Seizure
Marketedbimekizumab
Plaque Psoriasis (Psoriasis Vulgaris)
Marketedcertolizumab pegol
Ankylosing Spondylitis (Bekhterev's Disease)
Marketedfenfluramine hydrochloride
Unspecified Genetic Disorders
5-hydroxytryptamine receptor 2CSigma non-opioid intracellular receptor 1
Marketedmidazolam
Seizures
Marketedrotigotine ER
Parkinson's Disease
Marketedrozanolixizumab
Myasthenia Gravis
Marketedzilucoplan
Myasthenia Gravis
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that